HTAN clinical data consists of three tiers.
Tier 1 is based on the NCI Genomic Data Commons (GDC) clinical data model, while Tiers 2 and 3 are extensions to the GDC model.Tier | Description |
---|---|
1 | Seven categories of clinical data, based on the GDC clinical data model. See GDC Table below. |
2 | HTAN disease-agnostic extensions to the GDC clinical data model. |
3 | HTAN disease-specific extensions to the GDC clinical data model. |
Category | Description |
---|---|
Demographics | Data for the characterization of the patient by means of segmenting the population (e.g., characterization by age, sex, or race). |
Diagnosis | Data from the investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation. |
Exposure | Clinically relevant patient information not immediately resulting from genetic predispositions. |
Family History | Record of a patient's background regarding cancer events of blood relatives. |
Follow-up | A visit by a patient or study participant to a medical professional. A clinical encounter that encompasses planned and unplanned trial interventions, procedures and assessments that may be performed on a subject. A visit has a start and an end, each described with a rule. The process by which information about the health status of an individual is obtained before and after a study has officially closed; an activity that continues something that has already begun or that repeats something that has already been done. |
Molecular Test | Information pertaining to any molecular tests performed on the patient during a clinical event. |
Therapy | Record of the administration and intention of therapeutic agents provided to a patient to alter the course of a pathologic process. |
Tier 2 consists of disease-agnostic extensions to the GDC clinical data model.
Tier 3 consists of disease-specific extensions to the GDC clinical data model. This covers additional elements for Acute Lymphoblastic Leukemia (ALL), Brain Cancer, Breast Cancer, Lung Cancer, Melanoma, Ovarian Cancer, Pancreatic Cancer, Prostate Cancer and Sarcoma.
WARNING: Manifests provided on this page are for reference only. DO NOT USE THESE MANIFESTS FOR DATA SUBMISSION.
The interactive tables below are provided to help users understand the HTAN Data Model. The tables allow a user to view, search or download attributes either:
To view a specific manifest, click on the link in the Manifests tab. The manifest will appear in a new tab on the page. Navigate to the new tab to search for attributes or download the manifest.
To search for attributes among all manifests, navigate to the All Attributes tab and use the search box provided at the top of the tab. All attributes can also be downloaded as a csv file.